A combination of metformin and galantamine exhibits synergistic benefits in the treatment of sarcopenia

Age-associated sarcopenia, characterized by a progressive loss in muscle mass and strength, is the largest cause of frailty and disability in the elderly worldwide. Current treatments involve nonpharmacological guidelines that few subjects can abide by, highlighting the need for effective drugs. Pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tezze, Caterina, Amendolagine, Francesco Ivan, Nogara, Leonardo, Baraldo, Martina, Ciciliot, Stefano, Arcidiacono, Diletta, Zaramella, Alice, Masiero, Giulio, Ferrarese, Giulia, Realdon, Stefano, Blaauw, Bert, Detienne, Giel, Beliën, Ann T.J., Sandri, Marco, Mercken, Evi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445681/
https://www.ncbi.nlm.nih.gov/pubmed/37551712
http://dx.doi.org/10.1172/jci.insight.168787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445681/
https://www.ncbi.nlm.nih.gov/pubmed/37551712
http://dx.doi.org/10.1172/jci.insight.168787

Ejemplares similares